SightGlass Vision Reports Positive Four-Year Clinical Trial Outcomes for Myopia Control DOT Spectacle Lenses

Thursday, September 7 2023 | 12 h 32 min | News, Press Release

SightGlass Vision reported positive four-year outcomes from its pivotal CYPRESS study extension, which is evaluating the myopia control performance...

Read More

New SightGlass Vision Research Reinforces Myopia Control Efficacy and Safety of Diffusion Optics Technology™ Spectacle Lenses

Tuesday, April 25 2023 | 08 h 02 min | News, Press Release

SightGlass Vision announced positive outcomes of multiple studies designed to evaluate the performance of its Diffusion Optics Technology™...

Read More

SightGlass Vision Taps into Partner Companies for Leadership Positions

Friday, March 25 2022 | 13 h 34 min | Appointments, News, Press Release

SightGlass Vision, a joint venture between CooperCompanies and EssilorLuxottica to develop innovative technologies to address the global myopia...

Read More

SightGlass Vision Joint Venture Begins Operation

Friday, March 18 2022 | 11 h 51 min | News, Press Release

EssilorLuxottica and CooperCompanies announce the finalization of their joint venture agreement for SightGlass Vision This collaboration of two...

Read More

CooperVision: SightGlass Vision Diffusion Optics Technology Demonstrates Significant Reduction in Myopia Progression

Wednesday, October 6 2021 | 11 h 27 min | News, Press Release

CooperVision’s SightGlass Vision Business has revealed two-year clinical study data for its Diffusion Optics Technology™, which is specifically...

Read More